L-Carnitine plus cilostazol versus cilostazol alone for the treatment of claudication in patients with peripheral artery disease: a multicenter, randomized, double-blind, placebo-controlled trial
Difference in Gastrointestinal Risk Associated with Use of GLP-1 Receptor Agonists: A Real-World Pharmacovigilance Study
Tretinoin forces the skin to accelerate its renewal cycle through direct receptor activation, producing rapid but often irritating change
Read More #supplements #nutraceuticals #hearthealth #omega3s To view or add a comment, sign in New clinical guidance (2025 July, The American Journal of Clinical Nutrition) from leading medical societies reveals a game-changing approach to GLP-1 obesity treatment, and this one puts body composition monitoring at the center of care
Epithalon pineal-derived tetrapeptide referenced alongside DSIP in pineal-axis and circadian research
(These estimates are based on enrollment in March 2026 and factor in new plans for 2026, plan changes during open enrollment, and new enrollees, and therefore differ from other estimates published in a separate KFF brief, which are based on MedPACs projection of average monthly Part D premiums in 2026 using 2025 enrollment and not factoring in new plans, plan switching, or new enrollees.) The average premium for drug coverage in MA-PDs is heavily weighted by zero-premium plans because MA-PD sponsors can use rebate dollars from Medicare payments to lower or eliminate their Part D premiums
